Navigation Links
New Oxygen Biotherapeutics, Inc. Investor Presentation Available on Company Website
Date:9/29/2009

DURHAM, N.C., Sept. 29 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced that a new presentation for investors by company chairman and CEO, Chris Stern, is now available on the company website. The link to the presentation can be found under the "Presentations" heading on the Investor Relations section of the website at www.oxybiomed.com. It can also be accessed via the following direct link: https://oxybiomed.webex.com/oxybiomed/ldr.php?AT=pb&SP=MC&rID=233172&rKey=d75ac2ab8a411e23

The presentation is the same one that Stern will present at an investor conference in Zurich on Sept. 30, 2009. While the Zurich presentation will be in German, the presentation on the website is in English.

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and Defense Medicine(TM). The company has under development a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte®) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs as well as medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle cell crisis, trauma, wound care, decompression sickness, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, diabetes wounds and ulcers, and cosmetic applications. More information is available at www.oxybiomed.com.

SOURCE Oxygen Biotherapeutics, Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
2. Senexis and O2H (Oxygen Healthcare) Announce Medicinal Chemistry Collaboration
3. Finesse Introduces TruFluor(TM) DO, a Single-Use Optical Dissolved Oxygen Sensor and Transmitter
4. Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent
5. Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment
6. Oxygen Biotherapeutics, Inc. Expands Board of Directors
7. Oxygen Biotherapeutics, Inc. Adds Oxycyte TBI Clinical Trial Sites in Israel
8. Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
9. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
10. Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
11. Brain Monitor Eliminates Need for Routine Oxygen With Propofol - Friedberg's Triad Unveiled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 For today, ... on novel drug development and clinical research aimed at treating ... Inc. (NASDAQ: BSTG), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite Pharma ... ZIOP ). You can access our complimentary research reports on ... ...
(Date:4/19/2017)... ... April 18, 2017 , ... Alisa Wright, founder and CEO of ... the Purdue College of Pharmacy in Lafayette, Indiana. , The Distinguished Alumni Award ... in their careers and other scientific endeavors. , Wright began her career in ...
(Date:4/19/2017)... ... April 19, 2017 , ... ThermaGenix, the ... This event adds to several other early achievements at ThermaGenix, including the business ... , ThermaGenix will use proceeds from the Series A-1 round to:, ...
(Date:4/19/2017)... PUNE, India , April 19, 2017 ... Global Opportunity Analysis and Industry Forecast, 2014-2022 ," the global market was valued ... 2022, registering a CAGR of 9.6% from 2016 to 2022. ... ...      ...
Breaking Biology Technology:
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel visited the ... the DERMALOG stand together with the Japanese Prime Minster Shinzo Abe. ... largest German biometrics company the two government leaders could see the three ... as DERMALOG´s multi-biometrics system.   Continue Reading ... ...
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial ... ...
(Date:3/9/2017)... , Australia , March 9, 2017 ... data at the prestigious World Lung Imaging Workshop at ... Andreas Fouras , was invited to deliver the latest ... medicine. This globally recognised event brings together leaders at ... the latest developments in lung imaging. ...
Breaking Biology News(10 mins):